National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Forum on Neuroscience and Nervous System Disorders, Forum on Traumatic Brain Injury, Forum on Aging, Disability, and Independence, Katherine Bow...
Although traumatic brain injury (TBI) is a major cause of disability for adults over the age of 65, knowledge gaps and clinically relevant differences in TBI injury, recovery, and outcomes in this age group limit evidence-based care guidance. The Na...Loe edasi...
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Sheena M. Posey Norris, Eva Childers, Robert Pool
Glucagon-like peptide-1 receptor (GLP-1R) agonists, originally developed for type 2 diabetes patients and popularized by their ability to rapidly reduce body weight in patients with obesity, have recently received a lot of national attention. Repurp...Loe edasi...
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Sheena M. Posey Norris, Eva Childers, Celia Ford
Since artificial intelligences (AI) inception, AI and neuroscience have influenced each other to advance models of neural circuitry, analyze large and complex datasets, and inform the development of AI algorithms. This bidirectional relationship al...Loe edasi...
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Forum on Drug Discovery, Development, and Translatio
Attention deficit/hyperactivity disorder (ADHD) diagnosis and treatment among adults has increased over the past decade in the U.S. and globally. Evidence suggests adults with ADHD may be more likely to develop a substance use disorder, and there ar...Loe edasi...
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Sheena M. Posey Norris, Eva Childers, Robert Pool
Implantable brain stimulation has had a profound impact on neuroscience research and the treatment of central nervous system disorders by allowing physicians to directly intervene in the pathological neural circuits of their patients. To explore the...Loe edasi...
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Board on Global Health, Forum on Neuroscience and Nervous System Disorders, Forum on Microbial Threat
The National Academies Forum on Microbial Threats and Forum on Neuroscience and Nervous System Disorders hosted a hybrid public workshop in June 2023 to explore opportunities to advance research and treatment of infection-associated chronic illnesse...Loe edasi...
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Sheena M. Posey Norris, Eva Childers, Sarah Carter
A key step towards reducing the burden of central nervous system (CNS) disorders is the identification of disease-specific biomarkers that can help predict, monitor, and guide treatment development. Recent technological advances have led to an incre...Loe edasi...
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Sheena M. Posey Norris, Eva Childers, Lisa Bain
Chronic sleep disorders affect one in five Americans, and sleep deprivation costs significant U.S. GDP loss annually. Despite the indisputable biological importance of sleep, much remains unknown about underlying mechanisms. Th...Loe edasi...
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Clare Stroud, Sheena M. Posey Norris, Chanel Matney, Lisa Bain...
Psychiatric illnesses - such as major depressive disorder, anxiety disorder, substance use disorder, and posttraumatic stress disorder (PTSD) - are widely prevalent and represent a substantial health burden worldwide. Yet, conventional medications f...Loe edasi...
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Clare Stroud, Sheena M. Posey Norris, Lisa Bain
While significant progress has been seen in fields such as cardiovascular medicine and cancer in improving patient stratification and developing targeted drugs based on genetic findings, progress continues to lag for neuropsychiatric disorders. To a...Loe edasi...
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Clare Stroud, Chanel Matney, Lisa Bain
Mood disorders - including depression and bipolar disorder - are common, disabling, and potentially lethal disorders, characterized by a shortened lifespan from comorbid medical illness and rising suicide rates. Medications for these conditions have...Loe edasi...
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Clare Stroud, Sheena M. Posey Norris, Lisa Bain
Accumulating evidence gathered over the past three decades has demonstrated a biological basis for differences between men and women with respect to clinical features and treatment responses to several neuropsychiatric, neurodevelopmental, and neuro...Loe edasi...
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Clare Stroud, Amanda Wagner Gee, Lisa Bain
The cloud model of data sharing has led to a vast increase in the quantity and complexity of data and expanded access to these data, which has attracted many more researchers, enabled multi-national neuroscience collaborations, and facilitated the d...Loe edasi...
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Clare Stroud, Lisa Bain
On April 23 and 24, 2019 the Forum on Neuroscience and Nervous System Disorders convened a workshop titled Advancing Gene-Targeted Therapies for Central Nervous System Disorders in Washington, DC. This public workshop brought together experts and...Loe edasi...
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Clare Stroud, Sheena M. Posey Norris, Lisa Bain
To examine the promise, concerns, and challenges related to neuroscience research using genetically modified nonhuman primates, the National Academies of Sciences, Engineering, and Medicine hosted a public workshop on October 4, 2018, bringing toget...Loe edasi...
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Clare Stroud, Daniel Flynn, Lisa Bain
The critical importance of using mobile technology is clear to anyone in the health professions, particularly those who treat people with central nervous system (CNS) disorders. To explore current developments and opportunities for using mobile tech...Loe edasi...
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Clare Stroud, Noam I. Keren, Lisa Bain
Despite substantial advances in developing treatments for the serious illnesses that affect people worldwide, there remains a tremendous unmet need in the treatment of complex neurologic diseases, including neuropsychiatric and neurodegenerative dis...Loe edasi...
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Clare Stroud, Sheena M. Posey Norris, Lisa Bain
Chronic pain is one of the most prevalent, costly, and disabling health conditions in the United States. Estimates show that more than 11 percent of the American population suffer from chronic pain, yet the federal pain research investment has been...Loe edasi...
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Sheena M. Posey Norris, Noam I. Keren, Lisa Bain
Neuroinflammation is a burgeoning area of interest in academia and biopharma, with a broadly acknowledged role in many central nervous system (CNS) disorders. However, there is little agreement on the pathophysiological mechanisms that underlie the...Loe edasi...
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Clare Stroud, Noam I. Keren, Sheena M. Posey Norris, Lisa Bain...
Compared with other disease areas, central nervous system (CNS) disorders have had the highest failure rate for new compounds in advanced clinical trials. Most CNS drugs fail because of efficacy, and the core issue underlying these problems is a poo...Loe edasi...
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Clare Stroud, Noam I. Keren, Lisa Bain
Multimodal therapy approaches that combine interventions aimed at different aspects of disease are emerging as potentialand perhaps essentialways to enhance clinical outcomes for patients with psychiatric and neurological disorders. In order to exam...Loe edasi...
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Clare Stroud, Lisa Bain, Sheena M. Posey Norris
On March 3-4, 2016, the National Academies of Sciences, Engineering, and Medicines Forum on Neuroscience and Nervous System Disorders held a workshop in Washington, DC, bringing together key stakeholders to discuss opportunities for improving the i...Loe edasi...
National Academies of Sciences, Engineering, and Medicine, Institute of Medicine, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Sheena Posey Norris, Lisa Bain
Health information technology is providing patients, clinicians, and researchers with access to data that will enable novel approaches to science and medicine. Digital health records (DHRs) are capable of being shared across different health care se...Loe edasi...
National Academies of Sciences, Engineering, and Medicine, Institute of Medicine, Board on Global Health, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Bruce M. Altevogt, Erin Hammers Forstag, Sheena Posey Norris...
Mental, neurological, and substance use (MNS) disorders have a substantial impact on global health and well-being. Disorders such as depression, alcohol abuse, and schizophrenia constitute about 13 percent of the total burden of disease. Worldwide,...Loe edasi...
National Academies of Sciences, Engineering, and Medicine, Institute of Medicine, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Clare Stroud, Sheena Posey Norris, Lisa Bain
Based on advances in biotechnology and neuroscience, non-invasive neuromodulation devices are poised to gain clinical importance in the coming years and to be of increasing interest to patients, clinicians,health systems, payers, and industry. Evide...Loe edasi...
National Academies of Sciences, Engineering, and Medicine, Institute of Medicine, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Clare Stroud, Lisa Bain
Major depressive disorder (MDD) is recognized worldwide as a major cause of disability, morbidity, and mortality. According to the World Health Organization, unipolar depressive disorders affect more than 150 million people around the world and repr...Loe edasi...
Institute of Medicine, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, Forum on Neuroscience and Nervous System Disorders, Clare Stroud, Christopher DeFeo, Evelyn Strauss, Sheena M. Posey Norris...
The Institute of Medicine (IOM) Forum on Neuroscience and Nervous System Disorders, in collaboration with the IOM Forum on Drug Discovery, Development, and Translation, convened a workshop on January 20-21, 2015, to explore policy changes that might...Loe edasi...
Institute of Medicine, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Bruce M. Altevogt, Clare Stroud, Christopher Palmer, Sheena M. Posey Norris
This title is the summary of a workshop convened by the Institute of Medicines Forum on Neuroscience and Nervous System Disorders on October 28 and 29, 2014, in Washington, DC, to explore future workforce needs and how these needs should inform trai...Loe edasi...
Institute of Medicine, Board on Global Health, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Bruce M. Altevogt, Theresa M. Wizemann, Sheena M. Posey Norris, Diane E. Pankevich
In 2011 the Grand Challenges in Global Mental Health initiative identified priorities that have the potential to make a significant impact on the lives of people with mental, neurological, and substance use disorders. Reduction of the cost and impro...Loe edasi...
Forum on Neuroscience and Nervous System Disorders, Board on Health Sciences Policy, Institute of Medicine, Sheena M. Posey Norris, Diana E. Pankevich, Miriam Davis, Bruce M. Altevogt
Presents the summary of a workshop convened by the IOM Forum on Neuroscience and Nervous System Disorders to examine opportunities to accelerate early phases of drug development for nervous system drug discovery....Loe edasi...
